Monografie
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
- Sprache
-
Englisch
- Identifier
-
1129957578
Thema
Systemic Sclerosis; Hautkrankheit; Dermatologie; Hochschulschrift
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
Evaluation of the efficacy of the tyrosine kinase inhibitor Nintedanib and characterization of the role of the tyrosine-phosphatase SHP2 in preclinical models of Systemic Sclerosis
Inhibition of Phosphodiesterase 4 (PDE4) Reduces Experimental Fibrosis by Interfering with the Release of Interleukin-6 from M2 Macrophages
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
Einfluss von Tocopherol auf UV-induzierte NF-κB-Regulation [NF-kappaB-Regulation] und Lipidperoxidation in HaCaT-Keratinozyten
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
NCOA3 and SOCS3 as novel factors in the pathogenesis of systemic sclerosis-related tissue fibrosis
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome
Interplay of mtDNA, metabolism and microbiota in the pathogenesis of AIBD
Quantification and Functional Characterization of CD16 Positive Monocytes in Multiple Sclerosis
Evaluation of the efficacy of the tyrosine kinase inhibitor Nintedanib and characterization of the role of the tyrosine-phosphatase SHP2 in preclinical models of Systemic Sclerosis
Inhibition of Phosphodiesterase 4 (PDE4) Reduces Experimental Fibrosis by Interfering with the Release of Interleukin-6 from M2 Macrophages
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
Einfluss von Tocopherol auf UV-induzierte NF-κB-Regulation [NF-kappaB-Regulation] und Lipidperoxidation in HaCaT-Keratinozyten
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
NCOA3 and SOCS3 as novel factors in the pathogenesis of systemic sclerosis-related tissue fibrosis
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome
Interplay of mtDNA, metabolism and microbiota in the pathogenesis of AIBD
Quantification and Functional Characterization of CD16 Positive Monocytes in Multiple Sclerosis
Evaluation of the efficacy of the tyrosine kinase inhibitor Nintedanib and characterization of the role of the tyrosine-phosphatase SHP2 in preclinical models of Systemic Sclerosis
Inhibition of Phosphodiesterase 4 (PDE4) Reduces Experimental Fibrosis by Interfering with the Release of Interleukin-6 from M2 Macrophages
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
Einfluss von Tocopherol auf UV-induzierte NF-κB-Regulation [NF-kappaB-Regulation] und Lipidperoxidation in HaCaT-Keratinozyten
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
NCOA3 and SOCS3 as novel factors in the pathogenesis of systemic sclerosis-related tissue fibrosis
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome
Interplay of mtDNA, metabolism and microbiota in the pathogenesis of AIBD